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the mutants selected for loss of reactivity with two monoclonal antibodies and previously described, a model of the
structure of gB, and the predicted changes in the structure of
gB induced by the mutations. We should note that after the
sequencing of the wild-type HSV-1(F) gB gene was completed, a paper describing the nucleotide sequence of HSV-1
strain KOS [HSV-1 (KOS)] gB was published by Bzik et al.
(10). Although the differences between the sequences of
KOS gB and F gB are minor, there are significant differences
in the interpretation of the structural consequences of the
deduced amino acid sequence.

The long-term objective of this study is to dissect the
domains of a herpes simplex virus 1 (HSV-1) gene. We
selected the glycoprotein B (gB) gene for several reasons.
First, gB appears to be essential for production of infectious
virus inasmuch as ts mutants mapping in that gene have been
isolated (11, 25, 34, 36). Second, the phenotypes of the
mutants obtained to date suggest that the gB gene has
multiple functions. Thus, the gene may be essential for
penetration of the virus into the cells (34, 54). The observations that syn loci map in the domains of gB (13, 30, 35, 51)
and of other genes (35, 45a, 48) suggest that gB interacts with
several different proteins and that mutations in any of these
proteins may cause aberrant interaction, manifest by the syn
phenotype (51). In addition, the wild-type virus gB exists as
a dimer (54), and hence it contains cognitive sites for itself as
well as for other proteins. The preeminent reason for the
selection of the gB gene is that its product is incorporated
into membranes and appears on the surface of both virions
and infected cells. Because of this property, antibody to gB
can be used to select mutants in that gene.
In a preceding paper we described a panel of distinct
monoclonal antibodies to gB, a series of spontaneous and
mutagen-induced mutants nonreactive in at least one immune reaction with two monoclonal antibodies to gB, preliminary mapping of the mutations by marker rescue or
marker transfer, and a technique for rapid selection of
mutants reactive or nonreactive with specific monoclonal
antibodies (30). Those studies laid the groundwork for the
analyses in this paper. We report here the nucleotide sequence of the domain of the gB gene of HSV-1 strain F
[HSV-1(F)], the specific amino acid substitutions in three of
*

MATERIALS AND METHODS
Reagents. Restriction enzymes were obtained from Bethesda Research Laboratories, Gaithersburg, Md.; Pharmacia P-L Biochemicals, Piscataway, N.J.; and New England Biolabs, Beverly, Mass.; and were used according to
the instructions of the suppliers. T4 DNA ligase, Escherichia
coli DNA polymerase I large fragment (Klenow fragment),
and calf intestinal alkaline phosphatase were from Boehringer Mannheim Biochemicals, Indianapolis, Ind. T4 DNA
polymerase was from Bethesda Research Laboratories, sequencing primers were from New England Biolabs, and
deoxy- and dideoxy-nucleotide triphosphates were from
Pharmacia P-L Biochemicals.
Strains and vectors. Plasmid vectors pUC8 and pUC9 and
their host JM83 (58) were obtained from D. J. Messing
through Bethesda Research Laboratories.
Viruses, cells, and media. The properties of HSV-1(F), the
parent wild-type virus used in these studies, were described
elsewhere (15). The isolation and properties of the monoclonal antibody nonreactive mutants and the procedures for
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In this paper we report the nucleotide sequence and predicted amino acid sequence of glycoprotein B of
herpes simplex virus 1 strain F and the amino acid substitutions in the domains of the glycoprotein B gene of
three mutants selected for resistance to monoclonal antibody H126-5 or H233 but not to both. Analyses of the
amino acid sequence with respect to hydropathicity and secondary structure yielded a two-dimensional model
of the protein. The model predicts an N-terminal, 29-amino-acid cleavable signal sequence, a 696-amino-acid
hydrophilic surface domain containing six potential sites for N-linked glycosylation, a 69-amino-acid
hydrophobic domain containing three segments traversing the membrane, and a charged 109-amino-acid
domain projecting into the cytoplasm and previously shown to marker rescue glycoprotein B syn mutations.
The nucleotide sequence of the mutant glycoprotein B DNA fragments previously shown to marker transfer or
rescue the mutations revealed that the amino acid substitutions cluster in the hydrophilic surface domain
between amino acids 273 and 305. Analyses of the secondary structure of these regions, coupled with the
experimentally derived observation that the H126-5- and H233-antibody cognitive sites do not overlap, indicate
the approximate locations of the epitopes of these neutralizing, surface-reacting, and immune-precipitating
monoclonal antibodies. The predicted perturbations in the secondary structure introduced by the amino acid
substitutions correlate with the extent of loss of reactivity with monoclonal antibodies in various immunoassays.
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their propagation and for preparation of their DNA were as
described previously (30).
Recombinant DNA methods. The procedures for generating the panel of clones used in sequencing the gB gene, as
well as for cloning the mutant viral DNAs, were as previously described (30). The AvaI sites (see Fig. 1) were used to
clone the appropriate regions of R233/S9 and R126/B1 mutant DNAs as blunt-end fragments appropriate for sequencing into the SmaI site of pUC9. Because the AvaI site at
nucleotide 1792 in mutant R126/S8 was lost, the appropriate
DNA fragments of that mutant were cloned from Narl and
NarI-PstI digests (see Fig. 1) into pUC9.
DNA sequencing. All sequencing was performed by the
dideoxy technique (3, 53), with plasmid DNA as a template
(61) and pUC8 and pUC9 as vectors. DNA was purified on
glass powder (59) after an acid-base lysis of the bacteria (4).
Briefly, the alcohol precipitate from the lysis of a 100-ml
culture of bacteria was resuspended in 3 ml of TE (10 mM
Tris-1 mM EDTA, pH 8), to which 9 ml of 8 M NaClO4 was
added, followed by 300 ,ul of glass powder slurry prepared
by the method of Patterson (personal communication). After
1 to 2 h on ice, the glass was pelleted and washed once with
the salt solution and then twice with 50% EtOH-0.1 M
NaCI-1 mM EDTA. To minimize nicking and shearing of the
DNA, vortexing was kept to a minimum. The DNA was
eluted from the glass by incubation with 1 ml of TE at 37°C
for 30 min.
Approximately 0.6 pmol of subsequently linearized
plasmid was mixed with an appropriate dilution of primer
(normal M13 sequencing primer or M13 reverse sequencing
primer) in a total volume of 12 pl at 1 x HIN (50 mM NaCl,
10 mM MgCl2, 10 mM Tris [pH 7.4], 10 mM dithiothreitol).
The mixture was boiled for 5 min, quick-chilled on dry
ice-ethanol, and then allowed to anneal in a 24°C water bath
for 20 to 40 min before sequencing in a standard reaction.
For approximately the first half of the project, [oa-32P]dATP
(New England Nuclear Corp., Boston, Mass.) was used, and
for all subsequent studies, [a-35S]dATP from Amersham
Corp., Arlington Heights, Ill., was used (3). A 3:1 mixture of
2 mM dITP-1 mM dGTP was substituted for 1 mM dGTP
when making up the reaction mixtures, to resolve gel compressions (39, 52).
Gels were bonded to the glass plates, fixed, and dried by
the method of Garoff and Ansorge (24), and in the final
stages of the study, gradient buffer sequencing gels were
used (3). Gels were read, and the data were entered twice
into a General Automations SPC-16/45 computer, with a
sonic digitizer linked to software which allowed immediate
comparison of the two entries to ensure the accuracy of the
transcription.
Computer analysis of the sequences. The program of Queen
and Korn (46), running on an IBM 3081D; the sequence
analysis package obtained from Hugo Martinez, University
of California at San Francisco Biomathematics Computation
Laboratory, running on a Hewlett-Packard 9000; and
hydropathic analysis and graphing programs written by
P.E.P., also running on a Hewlett-Packard 9000, were used
in the analysis of the DNA sequence and in the modeling of
the structure of gB. Amino acids were designated by a
conventional three-letter or single-letter code; the number of
the amino acid is indicated throughout the text.
RESULTS
DNA and amino acid sequence analyses. (i) Nucleotide
sequence of the HSV-1(F) gB gene. To sequence the gB gene,
two series of DNA fragments were generated by the DNase
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I deletion subcloning strategy of Frischauf et al. (21). Each
series was generated from a 6-kilobase-pair BamHI-SalI
cloned DNA fragment containing the entire domain of the gB
gene. In each series, the deletions extended from one
terminus toward the other in increments of ca. 300 base
pairs. The generation and properties of the cloned DNA
fragment bank were described elsewhere (30) in connection
with the mapping of monoclonal antibody-resistant mutations in the HSV-1(F) gB gene. The terminal 250 to 300 bases
of the cloned DNA fragments were sequenced as described
above; both strands were sequenced in their entirety (Fig.
1). The diagram of the sequenced region (Fig. 1) shows the
position and orientation of the sequence relative to the HSV
prototype oriehtation, a restriction map, the sequencing
strategy, and potential translation initiation and termination
codons in each of the six reading frames. Figure 2 shows the
nucleotide and amino acid sequence of the domain of the gB
gene.
The domain of the gB gene has previously been defined by
the mapping of ts mutants, the syncytial phenotype (syn),
mutations affecting reactivity with monoclonal antibody, and
mRNA (10, 13, 27, 28, 30, 51). The mRNA encoding gB has
been shown to be transcribed from right to left in the
prototype orientation (10, 27, 51), whereas for consistency
with sequence and structural depictions later in the text it is
shown left to right in Fig. 1. After this work was completed,
the sequence of HSV-1(KOS) gB also was published (10). A
detailed description of the sequence differences is presented
in the legend to Fig. 2, and a discussion of the differences in
the interpretation of the structural consequences of the
deduced amino acid sequence is presented in the discussion.
The results (Fig. 1) indicate that the largest open reading
frame in phase 3 extending from left to right from the
translation initiation site at nucleotide 795 to the termination
site at nucleotide 3504 is the only reading frame compatible
with the known size of the protein and genetic markers
mapped within the domain of the gB gene. The only other
large open reading frame of sufficient size (phase 2 reading in
the opposite direction) is excluded by being anticomplementary to gB mRNA (27); it would yield a protein significantly
smaller than g13 and would lack the domain of the syn
mutations. The open frame in phase 3 reading from left to
right and encoding the nucleotide sequence of gB overlaps at
its 5'-terminal 332 nucleotides of an open frame in phase 2
reading in the same direction. The nucleotide sequence
suggests that the region may contain the C-terminal amino
acids of the protein associated with a recently identified
complementation group and a 5.6-kilobase mRNA mapping
between the ICP 8 and gB genes (14, 27, 43). We have
extended the open frame leftward to 261 amino acids. It is
noteworthy that the translation of this putative protein
terminates just 10 nucleotides before the translation initiation site of gB and that its coding sequence spans the
upstream promoter and regulatory region of gB.
Several sequences associated with transcription and translation were found within and adjacent to the reading frame of
gB. They specifically are as follows.
(a) A TATA box with the sequence ATATATT was
present at nucleotides 481 to 487, ahd the sequence CACA
previously associated with the site of initiation of transcription (8) was found, as predicted, beginning with nucleotide
508.
(b) The sequence ATTG at nucleotide 399 reads CAAT on
the opposite strand; inasmuch as it is 100 base pairs upstream from the transcription initiation site, it could serve as
a CAT box (8).
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FIG. 1. Domain of the HSV-1(F) gB gene. A, DNA sequence arrangement of HSV-1(F) DNA; B, partial restriction enzyme map of the
sequenced region. For convenience, the sequenced region is shown inverted relative to its orientation in the P arrangement of HSV-1 DNA.
The enzymes indicated are: AvaI, A; BamHI, B; Narl, N; PstI, P; PvuII, V; and XhoI, X. The AvaI and Narl sites shown were those that
were used for subcloning cloned DNA fragments from DNAs of monoclonal antibody-resistant mutants. The numbers indicate the distance
in nucleotides from the first nucleotide of the left XhoI recognition site. C, Map of the sequencing overlaps. The dot at the beginning of each
line indicates the position of the first nucleotide of a sequenced clone. The arrow indicates the direction and the approximate extent of
sequence read from that clone. D, Map of potential translation initiation codons (ball on stem) and termination codons (stems) in each of the
three reading frames in both directions, as indicated by the arrows.

(c) The sequence GGGGGCGGGGGGCTCGGGTGCTGATTGG near this CAT box resembles the second distal
signal of the thymidine kinase gene (37) but differs from that
of the thymidine kinase gene in that the hexanucleotide core
sequence (38) is in an orientation inverted relative to that of
the thymidine kinase gene.
(d) Two polyadenylation signals, AATAAA (2), were
present downstream from the gB coding region. The first,
beginning with nucleotide 3523, was 16 nucleotides downstream from the translation termination codon at nucleotide
3504, whereas the second began at nucleotide 3766. One or
both of these sites could be used for termination of gB
mRNA and of the 5.6- and 10-kilobase mRNAs mapped to
this region (10, 27, 47). A sequence at position 3818 could
serve as the polyadenylic acid site for the family of X and ,/X
messages which initiate outside of BamHI-G and are transcribed from the strand opposite the one used by gB (27).
These mRNAs were previously shown to terminate in the
region defined by the SacI site at position 3237 and the
terminal BamHI site 764 nucleotides away (27).
(e) Efficient initiation of translation is thought to require a
complementary interaction between the mRNA sequence
and a portion of 18S rRNA (26, 56). A complementary
sequence with 8 of 10 bases matching the rRNA sequence
was found at nucleotide 732, i.e., 63 bases upstream from the
first AUG. This AUG is likely to be the initiation codon for
two reasons. First, the modified scanning hypothesis of
translation initiation (31) predicts that the first AUG in a
mRNA will serve as the initiation codon provided the local
environment is suitable. According to Kozak (31, 32), the gB
DNA sequence GCCATGCGC qualifies this AUG as an

efficient initiation site. Second, the sequence of amino acids
encoded by the DNA stretch immediately after this codon
was the only one within the gB gene that conforms with the
predicted structure of a signal sequence as discussed below.
Bzik et al. (10) also identified this AUG as the translation
initiation codon.
(f) The gB stop codon TGA was found at nucleotide 3504
and was followed by additional stop codons in all three
reading frames.
The molecular weight of the 903-amino-acid translation
product of the gB gene is 100,113; after cleavage of the
predicted 29-amino-acid signal sequence, the predicted molecular weight of the 874-amino-acid nonglycosylated protein would be 97,028. These molecular weights are well
within the range of the published apparent molecular weight
of gB (6, 41, 43, 57, 63).
(ii) Nucleotide sequences of DNA fragments from the domain of the gB gene carrying mutations conferring resistance
to gB-specific monoclonal antibodies. In previous studies we
described several HSV-1(F) mutants resistant to- monoclonal
antibodies in at least one immune reaction (30). Of these
mutants, three were chosen for sequencing of the mutated
site. The spontaneous mutant R126/S8 was resistant to
neutralization by monoclonal antibody H126-5; however,
the mutant gB reacted with this antibody in biotin-avidin-enhanced surface immunoassays and in immune precipitation
tests. The spontaneous mutant R233/S9 was resistant to
neutralization by monoclonal antibody H233; the mutant gB
reacted with this monoclonal antibody in biotin-avidin-enhanced surface immunoassays and in immune precipitation
tests. Both spontaneous mutants reacted with the heterolo-
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CTrCGAGAAGA TGCT GCGGGTCAGCGTCCACGGCGAGGTGCTGCCCGCGACGT TCGCCGCGGTCGCCAACGGCT T TGCGGCCGCGCaGCCGGCTTC TCGCCGCCCCTGACGGCG>GcGCGGGG

120

CACGGTCATCGACAACCGCTCGGCGCCGGGCGTGTTCGACGCGCACCGGT TCATGCGAGCGTCTCTCCT GCGACACCAGGTGGACCCGGcCCCTGCTCCCCAGCATCACCCATCGCT T CtT

240

CGAGC TCGTCAACGGGCCCCTCTT TGATCAC TCCACCCACAGCT tCGCCCAGCCCCCCAACACCGCGCTGTAT TACAGCGTCGAGA ACGTGGGGCTCCTGCCGCACC TGAAGGAGGAGCT

3fiO

CGCCCGGTTCATCATGGGGGCGGGGGGCTCGGGTGCTGATTGGGCCGTCAGCGAATTTCAGAGGTTTTACTGTTTTGACGGCATT TCCGGAATAACGCCCACTCAGCGCGCCGCCTGGCG

480

AT ATATTCGCGAGC TGA TTA TCGCCACCACAC TC T TTGCCTCGGTCT ACCGGTGCGGGGAGCTCGAGT TGCGCCGCCCGGAC TGCAGCCGCCCGACCTCCGAAGGT CGT TACCGTTrACCC

600

GCCCGGCGT ATATC TCACGT ACGACTCCGACTGTCCGCTGGTGGCCATCGTCGAGAGCGCCCCCGACGGC TGT ATCGtGCCCCCGGTCGZGTCGTGGTCTACGACCGAGACGT T TTCTCGA T
-29

7 20

MetArgGlnGlyAlaAlaArgGlyCysArgTrpPheVaIValTrpA
CCTCTACTCGGTCC TCCAGCACCTCGCCCCCAGGCTACCTGACGGGGGGCACGACGGGCCCCCGTAGTCCCGCCATGCGCCAGGGCGCCGCGcGGGGGTGCCGGTGGT TCGTCGTA TGGG

-1.1
840

-1

+1

l aLeuLeuG lyLeuThrLeuG lyVa lLeuVa lA laSerA laA laProSerSerProG lyThrProG lyVa lA laA laA laThrGIlnA laA laAsnG lyG lyProA)laThrProA laProP
CGC TC TTGGGGT TGACGC TGGGGGTCC TGGT GGCGTCGGCGGC TCCGAGT TCCCCCGGCACGCCTGGGGTCGCGGCCGCGACCCAGGCGGCGAACGGGGGACC TGCC AC TCCGGCGCCGC

27
960

roA laProG)lyProA laProThrG lyAspThrLysProLysLysAsnLysLysProLysAsnProProProProArgProA laG lyAspAsnA laThrVa lA laA laG lyH isA laThrL
67
CCGCCCC TGGCCCCGCCCCAACGGGGGACACGA AACCGA AGAAGAACAA AA AACCGAAAAACCC ACCGCCGCCGCGCCCCGCCGGCGA C AACGCGACCGTCGCCGCGGGCCACG;CCACCC 1080

leLysAlaGluAsnThrAspAlaAsnPheTyrValCysProProProThrGlyAlaThrValValGlnPhoGluGlnproArgArgCysproThrArgp 107
TGCGCGAGCACCTGCGGGACA TCAAGGCGGAGAACACCGATGCAAACT T T TACGTGTGCCCACCCCCCACGGGCGCCACGGTGGTGCAGT TCGAGCAGCCGCGCCGCTGCCCGACCCGGC 1200

euArgGluHisLeuArgAspI

roGluGlyGlnAsnTyrThrGluGlyI leAlaValValPheLysGluAsnI leAlaProTyrLysPheLysAlaThrMetTyrTyrLysAspValThrValSerGlnValTrpPheGlyH 147
CCGAGGGTCAGAACTACACGGAGGGCA TCGCGGTGGTCT TCAAGGAGAACATCGCCCCGTACAAGT TCAAGGCCACCA TGT ACTACAAAGACGTCACCGT TTCGCAGGTGTGGT TCGGCC 13 20

isArgTyrSerGlnPheMetGlyIlePheGluAspArgAlaProValProPheGluGluValI leAspLysI leAsnAlaLysGlyValCysArgSerThrAlaLysTyrValArgAsnA 187
ACCGC TAC TCCCAGTT T ATGGGGA TC TTTGAGGACCGCGCCCCCGTCCCC TTCGAGGAGGTGA TCGAC AAGA TC AACGCC AAGGGGGTC TGTCGGTCCACGGCCAAGT ACGTGCGC AAC A 14 40
snLeuG luThrThrA laPheH isA rgAspAspH isG luThrAspMetG luLeuLysProA laAsnA laA laThrArgThrSerArgG lyT rpH isThrThrAspLeuLysT yrA snProS 227
ACCTrGGAGACC ACCGCGT TTCACCGGGACGACCACGAGACCGACA TGGAGC TGA AACCGGCCAACGCCGCGACCCGC ACGAGCCGGGGC TGGC AC ACCACCGACC TCAAGT AC AACCCC T 1560

erArgValGluAlaPheHisArgTyrGlyThrThrValAsnCysI leValGluGluValAspAlaArgSerValTyrProTyrAspGluPheValLeuAlaThrGlyAspPheValTyrM 267
CGCGGGTGGAGGCGTTCCACCGGTACGGGACGACGGTAAACTGCATCGTCGAGGAGGTGGACGCGCGCTCGGTGTACCCGTACGACGAGT T TGTGCTGGCGACTGGCGACTT TGTGTACA 1680
etSerProPheTyrG lyTyrArgG luG lySerH isThrG luH isThrSerTyrA)laA laAspArgPheLysGIlnVa lAspGlIyPheTyrA laArgAspLeuThrThrLysA laArgA laT

307
TGTCCCCGTT T TACGGC TACCGGGAGGGGTCGCACACCGAACACACCAGC TACGCCGCCGACCGC TTCAAGCAGGT TGACGGC TTC TACGCGCGCGACC TCACCACCAAGGCCCGGGCCA 1800

hrA laProThrThrArgAsnLeuLeuThrThrProLysPheThrVa lA laT rpAspT rpVa lProLysArgProSerVa 1CysT hrMet ThrLysT rpG lnG luVa lA spGl1uMet LeuA 34 7
CGGCGC CGACCACCCGGAACC TGC TCACGACCCCCAAGT TCACCGTGGCC TGGGACTGGGTGCCAA AGCGCCCGT CGGT CTGC ACC A TGACC AAGT GGCAGGAGGTGGACGAGA TGC tGC 19 20

rgSerGluTyrGlyGlySerPheArgPheSerSerAspA 11
laeSerThrThrPheThrThrAsnLeuThrGluTyrProLeuSerArgValAspLeuGlyAspCysI leGlyLvsAspA 387
GCTCCGAGTACGGCGGCTCCTTCCGAT TCTCCTCCGACGCCATATCCACCACCTTCACCACCAACCTGACCGAGTACCCGCTCTCGCGCGTGGACC TGGGGGACTGCA TCGGCAAGGACG 2040

laArgAspAlaMetAspArgI lePheAlaArgArgTyrAsnAlaThrHisIl eLysValGlyGlnProG1nryrTyrLeuA1aAsnGlyGlyPheLeuI 1eAlaTyrGlnProLeuLeuS 427
CCCGCGACGCCA TGGACCGCA TCT TCGCCCGCAGGTACAACGCGACGCACATCAAGGTGGGCCAGCCGCAGT ACT ACCTGGCCAA TGGGGGCT TTCTGATCGCGT ACCAGCCCC TTCTCA 2 160

hhrThrSerSeerI
erlI eGGI uPhheeA laAArrgLLuGulGI n h eT h T yr A nsHis IGeGlIArAgrg H sVVa IAssnnAssMeMteteLG
HG
slGILuuTe
uT50
ulGIyyrgrVgVa A IaaI eeAI aaTrrpCCysGG Il euGeluGnIsnAHsn
CCACCTCCTCCATCGAGTTCGCCCGGCTGCAGTT TACGTACAACCACA TACAGCGCCATGTCAACGATATGT TGGGCCGCGT TGCCA TCGCGTGGTGCGAGCTGCAG^AATCACGAGC TGA 24100
hrLeuTrpAsnG luA laArgLysLeuAsnProAsnA la Il eA laSerA laThrVa lG lyArgArgVa lSerA laArgMet LeuG)lyAspVa lMetA laVa lSerThrCysVa lProVa lA 547
CCC TGTGGAACGAGGCCCGCAAGCTGA ACCCCAACGCCATCGCCTCGGCCACCGTGGGCCGGCGGGTGAGCGCGCGGA TGC TCGGCGACGT GA TGGCCGT CTCCACGTGCGT GCCGGTrCG 2 520
l aA laAspAsnVa lIl eVa lG lnAsnSerMetArgI leSerSerArgProG lyA laCysTyrSerArgProLeuVa lSerPheArgTyrG luAspG lnG lyProLeuVa lG luG lyG lnL 587
CCGCGGACA ACGTGA TCGTCCAAA AC TCGA TGCGCA TCAGC TCGCGGCCCGGGGCC TGC TACAGCCGCCCCC TGGT CAGCT T TCGGTrACGA AGACCAGGGCCCGT TGGT CGAGGGGC AGC 264 0

etiG^lyG luAsnAsnGIlvJLeuArgLeuThrArgAspA laI leGluProCysThrVa lG lyHi sArgArgTyrPheThrPheG lyG lyG lyTyrVa lTyrPheG luG luTyrA laTryrSerH
TGGGGGAGAACA ACGAGCTGCGGCTGACGCGCGATGCGATCGAGCCGTGCACCGTGGGACACCGGCGCTAC TTCACC TTCGGCGGGGGC TACGTGT AC TTCGAGGAGTACGCGTAC TCCC

G27

276.0

i sG lnLeuSerArgA laAspI leThrThrVa lSerThrPheIl eAspLeuAsnI leThrMetLeuG luAspH isG luPheVa lProLeuG luVa lTyrThrArgH isGIlu Il eLysAspS 667
ACCAGCTGAGCCGCGCCGACATCACCACCGTCAGCACCTTCA TCGACC TC AACA TCACCA TGC TGGAGGA TCACGAGT T TSTCCCCC TGGACGrGFGTACACCCGCCACGAGA TCAAGGACA 2880

erGl yLeuLeuAspTyrThrGluVa lGlnArgArgAsnG lnLeuH isAspLeuArgPheA laAspIl1eAspThrVa 1I leH isA 1aAspA laAstiA laA 1aMetPheA laG 1yl eLiGlyA 707
GCGGCCTGC TGGAC TACACGGAGGTCCAGCGCCGCAACC AGC TGCACGACC TGCGC TTCGCCGACA TCGACACGGTCA TCC ACGCCGACtiCCA ACGCCGCCA TGT TCGCGGGC:C T (GGCG 3000
1 aPhePheG luG lyMetG lyAspLeuGlyArgA laVa lGlyLysVa lVa lMetGlyl leVa lGl yGl yVa 1Va 1SerA laVa 1SerG lyva 1SerSerPheMetSerAsnProPsheGl1yA 7t17
CGT TC TTCGAGGGGATGGGCGACC TGGGGCGCGCGGTCGGCAAGG rGGTGA TGGGCA TCGTGGGCGGCGT GGT A TCGGCCGTGrTCGGGCGTGT CC TCCT TCATrGTrCCA ACCCClT T GGGG 3 120
l aLeuA laVa lGl yLeuLeuVa lLeuA laG lyLeuA laA laA laPhePheA laPheArgTyrVa IMetArgLeuGl nSerAsnProMetLysA laLeuTyrProLeuThrThi-LysG lL 7R7
CGC tGGCCGTGGGTCTGT TGGTCCTGGCCGGCCTGGCGGCGGCT TTCT TCGCC T TTCGCTACGTCATGCGGC TGCAGAGCAACCCCA TGAAGGCCCTGT ACCCGCT AACCACCA AGGAGC 3 2 4(

euLysAsnProThrAsnProAspA laSerG lyG)luG lyG luG luGlyG lyAspPheAspG luA laLysLeuA)laG)uA laArgGluMetIl]eArgTyrMetA laLeuVa ISerA laMetG 827
T CAAGAACCCC ACCA ACCCGGACGCGTCCGGGGAGGGCGAGGAGGGCGGCGAC T TTGACGAGGCCAAGCT AGCCGAGGCCCGGGAGATrGA TACGGT ACA TGG(CCCT GGTGTC rGCC A TGG 33650
1 uArgThrG 1uH isL ysA laLysLys LysG lyThrSerAl1aLeuLeuSerA)1aLysVqa lThrA spMe tVa lMe tArgLysArgA rgAsnThr AsnTVrThrG 1nVa 1ProA snL ysA spG 8G7
region.~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~26
AGCGCACGGAACAC AAGGCCAAGAAGAAGGGCACGAGCGCGC TGCT CAGCGCCA AGGTCACCGACATGGTCA TGCGCAAGCGCCGCA AC ACCAACT ACACCCAAGT TCCCAAC,AAAGACG 34SR
l yAspA laAspG luAspAspLeu
GTGACGCCGACGAGGACGACCTGTGACGGGGGGT TTGT TGTAAATAAAAACCACGGGTGT TAAACCGCATGTGCA TCT T TTGGT TTG rTTTG TTTGGTACGCCT T TTGTGTG^TGTGSGGAAG

8 t4
3B600

AAAGAAAAGGGAACACATAAACTCCCCCGGGTGTCCGCGGCCTGT TTCCTCTTTCCTTTCCCGTGACAAAACGGACCCCCT TGGTCAGTGCCG*ATTCCCCCCCCACGCCTTCC TCCAf GT 37 20
CGAAGGCTT TTGCATTGTAAAGCTACCCGCCTACCCGCGiCCTCCCAATAAAAAAAGAACATACACCAATGGGTCTTAT TTGGTA TTACCTGGT TTAT TTAAAAAGA TATACAC.TrAAGACA

1lR40

TCCCA TGGT ACCAAAGACCGGGGCGAA TCAGCGGGCCCCCATCA TCTGAGAGACGAACAAATCGGCGGCGCGGGCCGTGTC AACGTCCACGTGTGCTGCGC TGC lGGCGT TGACAAGGGC 3360

CCCGGCC TCCGCGTTGGATGCCTCCGGT TGGGATCC 3996

FIG. 2. Nucleotide sequence and predicted amino acid sequence of HSV-(F) gB. In the P arrangement of HSV-1(F) DNA, gB is
transcribed from right to left. Nucleotide 1 is the first nucleotide of the left Xhol site as shown in Fig. 1, and nucleotide 3996 is the last
nucleotide of the BamHl site at the left end of the BamHI fragment G of HSV-1(F) in the P arrangement. The TATA box and presumptive
transcription initiation sites are underlined with solid lines, and potential sites for N-linked glycosylation are underlined by a thick line with
diagonal stripes. In relation to the sequence shown, the published nucleotide sequence of the HSV-1(KOS) gB gene (10) begins at nucleotide
248 and terminates at nucleotide 3996. Both HSV-1(F) and HSV-1(KOS) have an identical number of amino acids. The amino acid sequences
differ at the following positions [shown as the KOS amino acid at the corresponding HSV-1(F) amino acid position]: His- 28, Pro-24, Ser-23,
Trp (between -23 and -22), Arg-21, Pro, 37, Thr+49, Thr+283, Val+523, and Leu+726. In addition, the deletion of two bases in KOS relative
to HSV-1(F) at nucleotide 915 resulted in a reading frameshift for a total of 19 amino acids (amino acids 12 to 30) until a one-base deletion
in the KOS sequence relative to that of F at position 962 returned the amino acid sequences to a homologous alignment. In addition to the
three nucleotides deleted in the coding sequence indicated above (nucleotide 915, 916, and 962), KOS lacks a nucleotide (3958) downstream
from the coding region. KOS contains 12 nucleotides absent in HSV-1(F); 3 are located between HSV-1(F) nucleotides 811 and 812 and code
for Trp, and the remainder are in the 3' noncoding region. In addition, there are 37 nucleotide substitutions, of which 27 are in the coding
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The results of the nucleotide sequencing of the relevant
regions are shown in Fig. 3 and 4. R126/S8 contains substitutions at amino acids 283, 305, and 443; R126/B1 contains
substitutions at amino acids 273 and 283; and R233/S9
contains a single substitution at amino acid 285.
Modeling of the gB structure. The secondary structure of
gB was predicted by a combination of the hydropathic
analysis of Kyte and Doolittle (33), the empirically based
secondary-structure analyses of Chou and Fasman (11) and
Garnier et al. (23), and the helical wheel models of Schiffer

gous monoclonal antibodies in all three tests. Moreover, the
resistance phenotype of both mutants was transferable to
wild-type HSV-1(F) by the corresponding 1,745-base-pair
PstI fragments extending from nucleotides 562 to 2307.
Bromodeoxyuridine-induced mutant R126/B1 failed to react
with monoclonal antibody H126-5 in all three immunoassays, although it reacted in all three tests with the heterologous H233 monoclonal antibody. The phenotype of this
mutant was mapped in marker rescue tests with wild-type
DNA fragments to nucleotides 1482 to 1869.

Nucleotide and Predicted Amino Acids Sequence

Vi rus

286

272

303

307

305
Lys Ala GLN Ala Thr
GCC
CaG GCC ACG
AAG

443
Glu Gln ASN Arg Lys
GAG CAG AaC CGC AAG

R126/S8

Gly Tyr Arg Glu Gly Ser His Thr Glu His Thr THR Tyr Ala Ala
GGC TAC CGG GAG GGG TCG CAC ACC GAA CAC ACC Acg TAC GCC GCC

R126/B1

Gly ASN Arg Glu Gly Ser His Thr Glu His Thr THR Tyr Ala Ala
GGC aAC CGG GAG GGG TCG CAC ACC GAA CAC ACC Acg TAC GCC GCC

Lys Ala Arg Ala Thr
AAG GCC CGG GCC ACG

285
Gly Tyr Arg Glu Gly Ser His Thr Glu His Thr Ser Tyr THR Ala
GGC TAC CGG GAG GGG TCG CAC ACC GAA CAC ACC AGC TAC aCC GCC

Lys Ala Arg Ala Thr
AAG GCC CGG GCC ACG

273

R233/S9

449

Glu Gln Ser Arg Lys
GAG CAG AGC CGC AAG

Gly Tyr Arg Glu Gly Ser His Thr Glu His Thr Ser Tyr Ala Ala
GGC TAC CGG GAG GGG TCG CAC ACC GAA CAC ACC AGC TAC GCC GCC

283

441

Lys Ala Arg Ala Thr
MG GCC CGG GCC ACG

H SV-1 (F)

283

Glu Gln Ser Arg Lys
GAG CAG AGC CGC AAG

FIG. 4. Nucleotide sequence and predicted amino acid sequence of DNA regions of HSV-1(F) and mutant viruses capable of inducing an
alteration in the reactivity of gB in marker transfer or marker rescue tests. Numbers are amino acid numbers. Amino acid number 1 is the
first amino acid after the putative site of the signal sequence cleavage. Substituted nucleotides are shown in lowercase letters, whereas
substituted amino acids are shown in uppercase letters.
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FIG. 3. Autoradiograms of portions of DNA sequencing gels showing some of the HSV-1(F) nucleotide sequence and the corresponding
sequences of three mutants selected for resistance to monoclonal antibodies in at least one immunoassay. The nucleotide sequence is shown
for nucleotides 1744 to 1693, reading on the strand complementary to the one shown in Fig. 2. The bases altered in the mutants relative to
the wild-type virus are indicated on the autoradiograms with dots. Letters A, C, G, and T under each lane indicate which chain-terminating
dideoxy-nucleotide triphosphate was present in the sequencing reaction loaded in that lane. The HSV-1(F) sequence was obtained with
[U-32P]dATP, and autoradiography was done on a wet nongradient gel. The mutant DNA sequences were obtained with [a-35S]dATP, and the
buffer gradient gel was fixed and dried before autoradiography (3).
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and Edmundson (55). The hydropathic profile and a model of
the secondary structure of gB are shown in Fig. 5 and 6,
respectively. The amino acid sequence predicts a signal
sequence (shown in Fig. 5 but not in Fig. 6), a hydrophobic
membrane-spanning domain, a cytoplasmic domain, and a
hydrophilic domain predicted to project from the surfaces of
virion envelopes and membranes of infected cells. It is
convenient to describe each domain separately.
(i) The signal sequence domain. Since gB is a membranebound glycoprotein, it could be predicted to possess a
membrane insertion (signal) sequence and a potentially
independent membrane anchor region. A region extending
from amino acids -29 to -1 has the characteristics of a
cleavable signal sequence and therefore should be unable to
serve as an anchor sequence. The findings specifically were
as follows.
(a) A hydrophobic sequence of 17 amino acids containing
a single polar residue (Thr) was found from Trp-19 to Ala-3.
This region is of sufficient length to serve as the hydrophobic
core of a signal sequence but is not long enough to serve as
an anchor (17, 45, 60).
(b) A characteristic structure of signal sequences is the
presence of a hydrophobic region predicted by Chou and
Fasman analysis to have both a-helical- and n-sheet-forming
potential (45). Hydrophobic sequences with such potentials
are found in ,-sheet conformation when analyzed by circular
dichroism in aqueous solvents and in a-helical conformation
when analzyed in nonpolar solvents (50), even if, as is the
case with gB, the ,-sheet potential is higher than the
a-helical potential.
(c) The sequence Val-13-Val-12 was found at positions 7
and 8 of the hydrophobic core. Both this sequence and its
position within the core are highly conserved in signal
sequences of both eucaryotes and procaryotes (45).
(d) Another characteristic of signal sequences is that the
hydrophobic sequence is preceded by positively charged
residues (45); in gB, the hydrophobic core was preceded by
a 10-amino-acid region containing three positively charged
amino acids.

(e) The sequence Ala_3-Ser-2-Ala-, corresponded exactly
with the sequence Ala-X-Ala, which is the most common
sequence found preceding the signal peptidase cleavage site
(45, 60). Ser is commonly found in the X position.
(f) A predicted 1-turn is usually found before or after the
cleavage site (45); the Ala_3-Ser-2-Ala-1 sequence of gB
was followed immediately by a 1-turn.
On the basis of these considerations, Ala,1 is predicted to
be the N-terminal amino acid of the mature protein.
(ii) The hydrophobic transmembrane domain. This domain
is readily apparent in the hydropathic profile (Fig. 5) as three
hydrophobic peaks, each ca. 20 amino acids in length. The
hypothesis that this domain contains three antiparallel segments traversing the membrane, each segment being connected to the next by a short turn region, is supported by the
following considerations.
(a) Arguments for the necessity of membrane-traversing
segments to be in a helical conformation have been presented previously (17). The Chou and Fasman analyses of
the three segments predict that the first (Ala+697 to Arg+717)
and the third (Phe+745 to Phe+765) segments have an ahelical structure. The second segment (Val+722 to Ser+742)
has both a-helical and 1-sheet potential, but its 1-potential is
higher than its a-helical potential. As was indicated above
with respect to the likely conformation of the signal sequence, such regions are likely to adopt an a-helical conformation in the nonpolar environment of the lipid bilayer. A
striking consequence of the model in Fig. 6 is that in a helical
wheel arrangements (not shown) (55), small side-chain amino
acids would cluster on one face of segments 1 and 3, whereas
both small side-chain amino acids and polar residues (Ser)
would cluster on one face of segment 2. Such an arrangement would permit these faces to pack closely and form
intersegment hydrogen bonds. In such an arrangement the
faces exposing larger nonpolar residues of the triple helical
cluster would be oriented toward the lipid environment of
the membranes.
(b) The turn between segments 1 and 2 is formed by
Ala + 718-Val + 719-Gly + 720-Lys + 721 immediately after
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FIG. 5. Hydropathic profile of gB. The determination of relative hydropathy as a function of position along the amino acid sequence was
done as described by Kyte and Doolittle (33), with a moving window of seven amino acids. The resulting profile was then smoothed by taking
its average in a moving window of three points, and the smoothed profile was plotted. The x-axis is drawn so that points above it are of greater
than average hydrophobicity as defined by Kyte and Doolittle (33). The thickened lines identify the predicted cleaved signal sequence (A),
the domain of the molecule whose secondary structure is altered in the monoclonal antibody-resistant mutants as described later in the text
(B), and the three hydrophobic peaks of the predicted membrane-traversing domain (C). Amino acid 1 is the amino acid predicted to follow
the signal peptidase cleavage site.
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T5
S3

T6

H6

T4

SI

HI

H12

77

H16

H17

Tll

FIG. 6. Predicted membrane orientation and secondary structure of gB. The prediction was based on a combination of hydropathic
analysis (33), empirically based secondary structure analysis (11, 23), and helical wheel analysis (55). Two domains containing internal Pro
residues are shown as helical domains, notwithstanding the Chou and Fasman predictions, because the probability of these domains forming
a helix was greater than five times their probability of being found in any other structure according to the predictions of Garnier et al. (23).
a-Helical regions are indicated as helices, ,-sheets are indicated as zig-zags, and chain direction changes were drawn only at predicted
,-turns. For the purpose of discussion and reference, the major helical, sheet, and turn domains were numbered from the amino terminus and
prefixed with the letters H, S, and T, respectively. Sites for potential N-linked glycosylation are indicated with thickened circles. Amino acids
are numbered in 100's, beginning at the amino acid predicted to follow the signal peptidase cleavage site. The membrane is indicated by the
stippled band. A standard one-letter amino acid code was used throughout: Ala, A; Arg, R; Asn, N; Asp, D; Cys, C; Gin, Q; Glu, E; Gly,
G; His, H; Ile, I; Leu, L; Lys, K; Met, M; Phe, F; Pro, P; Ser, S; Thr, T; Trp, W; Tyr, Y; Val, V.
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Arg + 717. At least part of the turn projects outside the
membrane. The turn between segments 2 and 3 is formed by
Ser+ 742-Asn + 743-Pro+ 744-Phe+745; Ser+ 742 and Phe+745 are
within the helical structure and are likely to be within the
membrane.
(c) Segment 1 contains three charged residues (Glu+710,
Asp+ 714, and Arg+ 717). Asp+ 714 and Arg+ 717 would occur
on the same side of the helix and would be able to form a
charge-neutralizing salt bridge. The thermodynamic analyses of Engelman and Steitz (17) predict that the thermodynamic stress is not so prohibitive as to preclude their
presence is the membrane.
(iii) The cytoplasmic domain. Because the hydrophobic
region is predicted to traverse the membrane an odd number
of times, the immediately adjacent domains of the gB must
be located on opposite sides of the membrane. The placement of the C-terminal domain on the underside of the
membrane is based on the absence of effective glycosylation
sites in the C-terminal region and the presence of both
effective glycosylation sites (Asn-X-Ser/Thr, where X is not
Pro) (49) and epitopes for neutralizing monoclonal antibodies on the N-terminal domain. The turn dotnains T10 and Tll
and the helical domains H16 and H17 (Fig. 6) are shown as
predicted from their amino acid sequence. Of the 109 amino
acids in this domain, 39 are charged, and the net charge is
positive.
(iv) The hydrophilic surface domain. The hydrophilic domain N terminal to the hydrophobic trans-membrane region
is shown as predicted from the amino acid sequence in an
unfolded, two-dimensional interpretation with little regard to
possible three-dimensional interactions. The amino acid
sequence predicts at least 7 1-sheet domains, 11 major turn
domains, and 17 helical domains with more than 10 amino
acids. It is of interest that the six efficient glycosylation sites
are located at the junction of helical or 1-sheet structures
with predicted turns, and hence they may be exposed to the
external environment of the molecule.
(v) The predicted secondary structures of wild-type and
mutated H233 and H126-5 monoclonal antibody cognitive
sites. Relevant to the consideration of the structure of H233
and H126-5 monoclonal antibody cognitive sites are the
following considerations.
(a) The immune assays used in the characterization of the
monoclonal antibody-resistant mutants previously published
(30) were neutralization, biotin-avidin-enhanced surface immunoassay, and immune precipitation tests. Analyses of the
mutants revealed a hierarchical order of sensitivity of the
tests to perturbations in structure introduced by mutations.
Thus, mutants which failed to react with a monoclonal
antibody in immune precipitation tests also failed to react in
biotin-avidin-enhanced surface immnunoassays and in neutralization tests. Conversely, mutants selected for resistance
to neutralization reacted with the corresponding antibody in
all other tests. These results indicate that mutations which
yielded nonimmune precipitating gB introduced greater perturbations than those that rendered the gB nonreactive in
biotin-avidin-enhanced surface immunoassays. Minor perturbations which affected neither of these reactions could
abolish neutralization.
(b) Mutant R126/B1 reacted with H233 but not with
H126-5 monoclonal antibodies in immune reactions, i.e.,
neutralization, biotin-avidin-enhanced surface immunoassays, and immune precipitation. Nucleotide sequence analysis (Fig. 4) showed that it contains two amino acid substitutions, i.e., Tyr+273 to Asn, and Ser+283 to Thr. The mutant
was rescued by DNA fragments spanning both mutated
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HSV-1I (F)
A

308f+
B

R126/S8

C

R126/Bl
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FIG. 7. Predicted secondary structure of the gB domains of
H126-5 and H233 monoclonal antibody-resistant mutants mapped by
marker transfer or rescue and containing amino acid substitutions.
A, Predicted secondary structure of the HSV-1(F) gB for amino
acids 264 to 308, as shown in Fig. 5; B, C, and D, predicted
secondary structure of R126/S8, R126/B1, and R233/S9, respectively. The secondary structure alterations were determined by the
method of Chou and Fasman (11) and are represented as described
in the legend to Fig. 5. The substituted amino acids are indicated
with thickened circles.

sites, but not by a DNA fragment containing the Thr+283
substitution three nucleotides from one of its termini (30).
Mutant R126/S8 contains three substitutions, i.e., Thr for
Ser+283, and Gln for Arg+305, and Asn for Ser+443. This
mutant reacted with H233 in all itnmune tests and with
H126-5 in immune precipitations and biotin-avidin-enhanced
immunoassays but not in neutralization tests. These results
suggest that the cognitive (epitopic) site for 11233 is different
from the mutations in the R126/B1 and R126/S8 gB genes and
that the major perturbation in the H126-5 cognitive site was
introduced by the Asn+273 substitution rather than by the
Gln+305 and Asn+443 substitutions, and hence the H126-5
cognitive site is located to the N-terminal side of Ser+283
rather than to the C-terminal side of that aminQ acid in the
diagram of HSV-1(F) shown in Fig. 7. Secondary structure
analyses of R126/S8 gB (Fig. 7B) predict that the substitution
of Thr for Ser+283 would result in the loss of a 1-turn and of
one a-helical residue and the generation of a four-residue
1-sheet. The substitutions of Gln for Arg+305 and Asn for
Ser+443 do not grossly alter the predicted secondary structure of the H126-5 epitopic site in R126/S8, but the substitu-
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tion of amino acids with different hydrogen-bonding capabilities or side chain size, or both, could still have an effect on
epitopic conformation. The substitution of Thr for Ser+283
and the substitution of Asn for Tyr+273 in R126/B1 (Fig. 7C)
could grossly perturb the intervening region because, in
addition to the predicted loss of the ,B-turn and of one ac-helix
residue with the gain of a four-residue 1-sheet seen in
R126/S8, there would be the substitution of a ,B-turn for a
four-residue 1-sheet.
(c) Mutant R233/S9 contains a single substitution of Thr+385
for Ala. This mutant reacted in all three immunoassays with
H126-5 and H233 monoclonal antibodies in biotin-avidin-enhanced surface immunoassays and immune precipitation
tests. The observed perturbation is therefore minimal; because the mutation at amino acid 283 has no effect on the
reactivity with H233, it could be predicted that the H233
cognitive site is different from amino acid 283 and is to the
C-terminal side of Ala,285 in wild-type gB. The substitution
of Thr for Ala, 285 causes the loss of a predicted turn and two
resid'ues of an ox-helix, with their replacement by a five-residue 1-sheet (Fig. 7D).
It is of interest to note that of the three mutants sequenced, two (R126/B1 and R126/S8) contain multiple mutations. R126/S8 contains four altered nucleotides resulting
in three amino acid substitutions (Fig. 4). This virus was
selected for resistance to neutralization by monoclonal antibody H126-5 from a nonmutagenized plaque-purified'stock
of HSV-1(F) (30). R126/B1 contains three altered nticleotides, resulting in two amino acid substitutions. This virus
was selected from a bromodeoxyuridine-mutagenized stock
of plaque-purifiedHSV-1(F) for its failure to react in a
biotin-avidin-enhanced surface immunoassay after an initial
selection for resistance to neutralization by monoclonal
antibody H126-5 (30). R233/S9, which contains a single
nucleotide substitution resulting in one amino acid substitution, was selected by the same procedure as was mutant
R126/S8, except the selecting monoclonal antibody was
H233. There was no correlation of amino acid substitution
frequency among the three mutants analyzed with respect to
the method of selection used.
DISCUSSION
The model of gB based on the nucleotide sequence of the
HSV-1(F) gB gene and presented in this report is tentative
and useful only for its predictive features. At 'this time,
however, the model is consistent with all of the features of
gB amenable to an immediate test.
(i) The model predicts a hydrophilic surface domain containing glycosylation sites and epitopes of neutralizing antibodies, a hydrophobic transmembrane anchor region, and a
hydrophilic positively charged cytoplasmic domain. We have
no direct evidence that the hydrophobic region designated as
the anchor sequence actually serves this purpose. However,
its structure is consistent with those of transmembrane
domains of other proteins (1, 62). Circumstantial evidence,
however, supports this view. Thus, the syn mutation maps
on the C-terminal side of this region, within the domain of
the protein predicted to be in the cytoplasm. The other syn
loci mapped to date are located in regions of the genome not
known to specify surface proteins (5, 45a). The hypothesis
that syn mutations result from aberrant complexes of several
viral proteins (51) predicts therefore that some of the diverse
proteins forming this putative complex must be located
within the lipid bilayer or underneath the membrane. It is

251

comforting therefore that the syn mutation in gB maps in the
protein domain assigned to the cytoplasm. The nearest and
only region with a structure capable of traversing the membrane is the one predicted by the model.
(ii) All of the predicted glycosylation sites are within
domains of the gene accessible to the surface of the protein.
However, it should be noted that evidence confirming the
existence of six oligosaccharide chains in partially or fully
processed gB is lacking.
(iii) The sites reactive with monoclonal antibodies H126-5
and H233 are in hydrophilic, exposed domains of the gB
model. This is consistent with the observation that both
H126-5 and H233 monoclonal antibodies efficiently neutralize the virus. It is of particular interest that resistance to one
monoclonal antibody does not affect the reactivity of the
epitope recognized by the other antibQdy, indicating that
although the mutations map close to each other, the perturbation in sequence and conformation induced by mutations
in one epitope are not of a sufficient magnitude to affect the
reactivity of the other. The mapping of the epitopes of gB is
in its infancy. In this paper we report the approximate
domain of the cognitive site of monoclonal antibody H125-6
and the approximate location of the H233 monoclonal antibody epitope. Mapping of additional independently derived
mutants resistant to H125-6 and H233 should define their
epitopes more precisely. In addition, selection and characterization of mutants to type-specific and nonneutralizing
monoclonal antibodies constituting the monoclonal antibody
panel previously described (30) should help outline the
surface of the tertiary structure of gB.
A striking feature of the model of gB structure is the
predicted triple pass through the membrane. Somewhat
similar arrangements of three membrane-spanning regions
have been predicted for the El glycoprotein of a coronavirus
(1) and for the hydrophobic subunits of the E. coli fumarate
reductase (62). Although gB is a relatively large protein, its
size is not so much greater than that of other membranebound glycoproteins which traverse the membrane only
once for size alone to dictate the requirement for the
presence of three interacting membrane-spanning segments.
The functional significance of the triple membrane pass
predicted by these studies remains obscure but is not likely
to be trivial. Among the possible functions of membrane
domains consisting of several closely packed helices is that
of an ion channel. Such a function has been associated with
several proteins whose structures have been shown or
predicted to include multiple helical passes through the
membrane (7, 9, 12, 16, 18-20, 28, 39, 40). A characteristic
feature of such structures is the amphipathic character of the
membrane-spanning segments, where one face of a membrane-spanning helix typically is nonpolar and the other face
contains several polar and charged residues. Such amphipathic helices may then associate in the membrane through
specific interactions between the faces containing polar and
charged residues, with the nonpolar faces becoming oriented
outward toward the membrane lipids, as we have predicted
for gB. The resulting structure is a protected pore through
which ionic traffic may be mediated with the ionic specificity
and control of transport being a function of the specific
structure.
The presence of machinery with the potential to modulate
intracellular ionic concentrations in an infected cell is of
interest because inversion of the transmembrane potential
due to perturbation of intracellular ionic concentrations after
infection by herpes viruses has been observed (22). Intracellular ionic perturbation as the basis for changes in the
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translational machinery of the infected cell has been postulated but never proven. This possible function of gB is,
fortuitously, testable.
A comparison of the published sequence of HSV-1(KOS)
gB by Bzik et al. (10) with the sequence reported here for
HSV-1(F) showed that in the region where both viruses were
sequenced there are a total of 53 nucleotide differences
which resulted in the insertion of an additional codon in
KOS relative to F, a 19-amino-acid sequence in F (18 in
KOS) where the sequences differ due to a shift of relative
reading frame, and 9 other amino acid substitutions (Fig. 2).
The amino acid substitutions do not make significant alterations in our predicted structure for the membrane orientation
and secondary structure of gB, except for the presence of a
Thr at amino acid 283 in place of the Ser seen in F. This is
the same substitution seen in two of the mutants sequenced
(R126/S8 and R126/B1). The significance of this difference is
unclear at this time. Our structural prediction based on the
sequence, however, differs considerably from that of Bzik et
al. (10). The specific areas of difference are as follows.
(i) Our prediction of a 29-amino-acid signal sequence with
the predicted cleavage occurring after Ala_3-Ser-2-Ala-, is
based on several well-defined properties of signal sequences
(44, 60). This is in contrast to the 41-amino-acid sequence
predicted by Bzik et al. (10) to serve as the signal sequence
because it is hydrophobic.
(ii) The prediction of a 44-amino-acid hydrophobic sequence serving as a membrane-spanning anchor (10) is
unlikely inasmuch as such a structure would be predicted
either to pass through the membrane twice as a hairpin of
two 22-amino-acid segments, thus placing the carboxy-terminal 109 amino acids of the protein on the exterior of the
infected cell or virion, or to adopt a heretofore unheard of
conformation in the membrane. Our prediction of three
membrane-spanning segments is based on the presence of
three hydrophobic peaks in a hydropathic analysis and
structural predictions within each segment which are compatible with a model of three interacting membrane-spanning
helices.
(iii) An important component of our model and a subject
not discussed elsewhere is the exquisite conformational
sensitivity of gB, as demonstrated in the gradient of reactivity of monoclonal antibody mutants in various immunoassays as a function of the denaturing ability of the assay
environment (30). The requirement for and consequences of
such conformational sensitivity remain objects of future
investigation.
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